BRS4-3-7 - Ketone Utilisation Capacity

(Using Ketones to Sustain Cellular Energy When Glucose Availability Changes)

1. Mission & Overview + Dietary Levers

Mission

Enable mitochondrial ketone utilisation so alternative fuel is available when glucose conditions shift.

Intervention Dominance: Diet/Lifestyle-Combined

Overview

Supports capacity to transport, metabolise, and utilise ketone bodies (beta-hydroxybutyrate and acetoacetate, alternative fuels the liver produces when glucose availability falls) as mitochondrial energy substrates when glucose conditions change. This pathway provides metabolic fuel flexibility distinct from the carbohydrate- or fat-transport routes covered elsewhere, becoming physiologically relevant during fasting, prolonged exercise, or carbohydrate-restricted eating patterns. Mitochondrial ketone-oxidation enzyme capacity, not just circulating ketone levels, determines how effectively this alternative fuel is actually used.

• Metabolises ketone bodies as alternative mitochondrial fuel.
• Becomes relevant during fasting, exercise, or carbohydrate restriction.
• Depends on ketone-oxidation enzyme capacity, not just circulating ketone levels.

2. Primary Biological Effects

↑ ketone utilisation; ↑ alternative fuel capacity; ↑ energetic resilience under changing substrate availability

3. Intervention Levers

4. Mechanistic Basis

Summary

Ketone bodies provide an alternative energy substrate that can be oxidised within mitochondria to generate ATP. During periods of reduced glucose availability, ketones can contribute meaningfully to whole-body and brain energy metabolism [Ramezani et al., 2023; López-Ojeda et al., 2023].

4.1 Scientific Findings (2)

Summary

5. BRS Pathways and Connections

5.1 BRS Pathways

• None listed

5.2 Cross-BRS Mechanism Relationships

Primary Mechanisms in other Biological Regulatory Systems that directly interact with, constrain or support this mechanism.

• BRS6-FM1-PM2 - Glycaemic Variability Regulation — biological connection relevant to this mechanism

5.3 Local BRS Mechanism Relationships

Related Primary Mechanisms within the same Biological Regulatory System that collectively support the integrated biological function.

• BRS4-FM3-PM6 - Carnitine-Mediated Fat Transport — Scope distinction: ketone utilisation and carnitine-mediated long-chain fatty-acyl transport are separate substrate routes. Their placement together describes alternative fuel handling, not equivalence of dietary interventions.
• BRS4-FM3-PM8 - Metabolic Fuel Switching — Scope distinction: PM7 addresses use of ketone substrates; PM8 addresses switching between fuel routes. Ketone availability or an estimated ketone metabolic rate does not independently establish overall switching capacity.

7. Phenome Connections

These mappings are translational relationships, not single-mechanism outcome claims. Phenomes are emergent functional patterns supported by multiple interacting PMs across the BRAIN Framework.

Cognitive Energy Stability — indirectOpen Page →→

Historical Phenome narrative, retained without new validation

These mappings are translational relationships, not single-mechanism outcome claims. Phenomes are emergent functional patterns supported by multiple interacting PMs across the BRAIN Framework.

Cognitive Energy Stability — indirectOpen Page →→

Stage 2A/2B dietary-target assessment — 23 October 2026

ENRICHED. Mitochondrial utilisation of ketone fuel, distinct from peripheral ketosis alone.

Add the exact four-day experimental dietary protocol under SOPs and a human dual-tracer PET Finding. Register reaction/fuel participants as biochemical context without a dietary-supply admission. Distinguish kinetic estimates of acetoacetate metabolism from inferred total ketone contribution; no universal ketogenic-diet recommendation.

Historical-content boundary: The inherited food/cofactor lists and Phenome interpretations remain preserved research records; this bounded update does not newly validate their generic dietary or brain-effect claims.

New implementation: 0 dietary-input admissions (0 completed Unset candidates), 1 practices, 2 biochemical participants, 1 unscored Findings. Existing accepted inputs, source assessments, mission, KCs, Phenome relationships and scores are retained.

Source-to-claim boundary: Assessment source. Stop after adjudicating the stated material candidate and tracing supported delivery. Keep uncertain specificity, formulation, anatomical or measurement links explicit; no negative evidence is inferred from incomplete retrieval.

8. References

• [1] Ramezani et al. (2023) — Ketone Bodies and Brain Energy Metabolism
• [2] López-Ojeda et al. (2023) — New Insights and Perspectives for Neurological Diseases
• [3] Fuehrlein et al. (2004) — Ketogenic Diet Metabolic Effects
• [4] de Guia et al. (2019) — Exercise and Skeletal Muscle NAD⁺ Salvage
• [5] Omori et al. (2024) — Exogenous Ketones and Ketogenic Diet in Clinical Contexts
• [6] van Oudheusden and Scholte (2002) — Efficacy of Carnitine in the Treatment of Children with Attention-deficit Hyperactivity Disorder
• [7] Öğütlü et al. (2022) — Mitochondrial Dysfunction in Attention Deficit Hyperactivity Disorder
• [8] Courchesne-Loyer et al. (2017) — Inverse relationship between brain glucose and ketone metabolism in adults during short-term moderate dietary ketosis: A dual tracer quantitative positron emission tomography study.
• [9] Croteau et al. (2018) — Ketogenic Medium Chain Triglycerides Increase Brain Energy Metabolism in Alzheimer’s Disease

PM-local source records

Historical reference narrative, retained

• Ramezani et al. (2023) — Ketone Bodies and Brain Energy Metabolism
• López-Ojeda et al. (2023) — New Insights and Perspectives for Neurological Diseases
• Fuehrlein et al. (2004) — Ketogenic Diet Metabolic Effects
• de Guia et al. (2019) — Exercise and Skeletal Muscle NAD⁺ Salvage
• Omori et al. (2024) — Exogenous Ketones and Ketogenic Diet in Clinical Contexts
• van Oudheusden and Scholte (2002) — Efficacy of Carnitine in the Treatment of Children with Attention-deficit Hyperactivity Disorder
• Öğütlü et al. (2022) — Mitochondrial Dysfunction in Attention Deficit Hyperactivity Disorder

Historical §3.1.1 dietary statements — scientific reconciliation required

Original placement: §3.1.1 Direct and/or Derived Dietary Requirements. The statements below are retained without textual alteration. No structured scientific admission decision was recorded for these bullets; none is assigned by this repair. They have not been deleted, rejected, newly validated or automatically promoted to SOPs.

• Lower-carbohydrate whole-food patterns ← vegetables, protein-rich meals, nuts, legumes when metabolic context supports ketone production
• Mixed macronutrient whole-food meals ← broader substrate-flexibility context
• Adequate protein intake ← amino-acid substrate support within varied fuel patterns

Review needed: distinguish identifiable biochemical inputs from food delivery, dietary patterns and generic support claims; verify PM-specific evidence before proposing any structured admission or section reassignment. Existing structured scientific records remain unchanged.